Pharma Foods International: Announcements of individual stocks regarding the continued selection of stocks in the JPX Nikkei Small and Mid Cap Index.
Pharma Foods International: As stipulated in the exclusive license agreement between PFI and Takeda Pharmaceutical Company Limited, a milestone has been achieved.
Pharma Foods International: Announcements of individual stocks: Notice of milestone achievement based on the license agreement with Takeda Pharmaceutical Company Limited
Pharma Foods International: Summary of consolidated financial results for the 9 months ended April 30, 2024 (based on Japanese accounting standards).
Pharma Foods: Announcement of the full transcript of the financial results briefing for the 2nd quarter of the fiscal year ending 2024/7
Pharma Foods International: (Delayed)Summary of Consolidated Financial Results for the Six Months Ended January 31, 2024 (Based on Japanese GAAP)
Pharma Foods International: (Progress of disclosure matters) Effects of the Reiwa 6 Noto Peninsula Earthquake (2nd report)
Pharma Foods International: Effects of the Reiwa 6 Noto Peninsula Earthquake
Pharma Foods International: (Delayed)Summary of Consolidated Financial Results for the Three Months Ended October 31, 2023 (Based on Japanese GAAP)
Pharma Foods International: Battery materials are born from eggs, construction of a platform for industrial use of eggshell membranes, adopted by NEDO for the “Bio Manufacturing Revolution Promotion Project”
Pharma Foods International: Notice regarding the opinions of the Board of Directors of the Company on shareholder proposals
Pharma Foods International: (Delayed)Summary of Consolidated Financial Results for the Year Ended July 31, 2023 (Based on Japanese GAAP)
Pharma Foods International: Notice regarding the business alliance between Takara Bio and Pharma Foods
Pharma Foods International: (Delayed) Summary of Consolidated Financial Results for the Nine Months Ended April 30, 2023 (Based on Japanese GAAP)
Pharma Foods International: (Delayed) Summary of Consolidated Financial Results for the Six Months Ended January 31, 2023 (Based on Japanese GAAP)
Pharma Foods International: Notice on cooperation with the capital business of Alby and Vermes
Pharma Foods International: Notice on the Establishment of Investment Business Limited liability Partnership (subsidiary)
Pharma Foods International: Statutory ex post disclosure document (company split) (Antegrad Co., Ltd.)
Pharma Foods International: Statutory pre-disclosure documents (company split) (Antegrad Co., Ltd.)
Pharma Foods International: Notice on signing a memorandum on the establishment of a joint venture company with a large drugstore in Vietnam
No Data